Do Weight-Loss Medications Work—and Who Can Use Them?

Weight-loss medication can help some adults with long-term weight management, but results vary and no single medicine works for everyone. The practical question is not simply whether a drug works: it is what a particular medicine has shown in studies, whether its approved use fits your situation, what risks matter for you, and whether you can access it at a manageable cost. Medicines are generally used alongside dietary, behavioral and physical-activity support, rather than on their own (UC Davis Health; Drugs.com).

What do the reported results mean?

A U.S. News Health report describes average body-weight loss of about 10%–15% in clinical trials of semaglutide (Wegovy). It also says some participants taking tirzepatide (Zepbound) lost 20% or more. Those are different kinds of figures—an average versus a result achieved by some people. The supplied reporting does not give enough detail about the trial populations or timeframes to use them as a direct comparison, much less as a prediction of what you would lose.

Medicines also act in different ways: prescription options may affect appetite, fullness, fat absorption or cravings (UC Davis Health). That is one reason to ask about a named medicine and its active ingredient rather than treating all weight-loss pills or injections as interchangeable.

Who may be eligible?

For the adult U.S. GLP-1 indications summarized by Drugs.com, the cited threshold is a body mass index (BMI) of 30 or higher, or 27 or higher with at least one weight-related condition. Its Saxenda information gives those thresholds for adults using that medicine with diet and exercise. These are descriptions of particular indications, not a universal eligibility rule for every weight-loss medicine.

A prescriber also needs more than a BMI number. Existing conditions, medical and family history, and potential side effects can affect the decision (U.S. News Health). Bring a current medication list and ask which details of your health history matter for the specific option under discussion. Eligibility does not mean a medicine is automatically a good fit.

The product name matters, too. Wegovy and Ozempic contain the same active ingredient, semaglutide, but the UC Davis Health explanation distinguishes Wegovy’s weight-management use from Ozempic’s use for type 2 diabetes. Likewise, Zepbound contains tirzepatide, which is also approved under the name Mounjaro for adults with type 2 diabetes. A shared ingredient—or a report that a diabetes medicine can cause weight loss—does not make the products’ approved uses identical.

Which risks belong in the conversation?

For injectable medicines, reported gastrointestinal effects include nausea, diarrhea and constipation; semaglutide can also cause vomiting. Rarer reported effects include inflammation of the pancreas or gallbladder (U.S. News Health; Cleveland Clinic). Orlistat, which works by changing fat digestion and absorption, can cause gas and diarrhea (Cleveland Clinic). Risks should therefore be checked for the particular medicine, not assumed from a general description of weight-loss drugs.

There is also an important health-history question for some injections. Thyroid tumors occurred in rats in studies of semaglutide and liraglutide injections; whether those medicines increase that risk in humans is unknown. Tell a clinician if you or a family member has had thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2), so they can assess the relevance to the medicine being considered (U.S. News Health).

Can you get it—and what happens over time?

Before pursuing a product, check its active ingredient, FDA-approved use, and prescription or over-the-counter (OTC) status. In the U.S., lower-dose orlistat sold as Alli is FDA-approved and available OTC; prescription-strength orlistat is sold as Xenical. Other options, including the combination medicines phentermine/topiramate and bupropion/naltrexone, require a prescription (Cleveland Clinic; Drugs.com). If something is advertised only as a “patch” or “peptide,” that description alone is not enough to identify its ingredient, approved use or evidence for it.

Approval does not settle affordability. Newer weight-loss drugs may not be covered by U.S. insurance because of their cost and lack of available generics (Drugs.com). Check coverage and expected out-of-pocket cost for the specific product and indication before making a treatment plan around it.

Finally, ask how long the proposed treatment is meant to be used. Some weight-loss medicines are intended for short-term use and others for longer-term management; weight can return after stopping (UC Davis Health). A useful discussion with a qualified prescriber covers the expected benefit, your relevant risks, what follow-up would involve, and what the plan would be if the medicine is ineffective, unaffordable or stopped.